Literature DB >> 17343850

GAP-43 expression is upregulated in retinal ganglion cells after ischemia/reperfusion-induced damage.

Frederike Dijk1, Arthur A B Bergen, Willem Kamphuis.   

Abstract

In response to injury, the adult mammalian retina shows signs of structural remodeling, possibly in an attempt to preserve or regain some of its functional neural connections. In order to study the mechanisms involved in injury-induced plasticity, we have studied changes in growth associated protein 43 (GAP-43) after retinal ischemia/reperfusion in the rat. GAP-43 is a marker for neuronal remodeling and is involved in synapse formation. Ischemic injury of the rat retina was induced by 60 min of ischemia followed by reperfusion times varying from 2h up to 4 weeks. GAP-43 mRNA levels were significantly increased between 12h and 72 h reperfusion with a peak around 24h. GAP-43 specific antibodies showed that the total amount of GAP-43 labeling in the inner plexiform layer was diminished after 12h of reperfusion by approximately 35% and remained at this level up to 1 week postischemia despite the reduction in thickness of this layer during this period resulting from the ischemia-induced cell loss. At 2 and 4 weeks reperfusion, the amount of labeling was reduced by 70%, simultaneously with a decrease of GAP-43 transcript level. Between 72 h up to 2 weeks postischemia, the induction of intense GAP-43 labeling was observed in NeuN- and beta-tubulin-positive ganglion cell somata and in horizontally and vertically oriented processes in the inner plexiform layer. Ischemia also induced GAP-43 expression in some GFAP-positive Müller cells. Double-labeling showed that in controls and after ischemia GAP-43 was expressed by some amacrine cells of the glycinergic (glycine transporter 1), calretinin-positive, and dopaminergic (tyrosine hydroxylase) subpopulations. No increase of GAP-43 expression levels was found in these amacrine cells. The results demonstrate that ganglion cells show an elevated expression of GAP-43 after ischemia-inflicted damage. These findings suggest a temporal window during which ganglion cells may remodel their neuronal network in the damaged retina.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17343850     DOI: 10.1016/j.exer.2007.01.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  27 in total

1.  Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin.

Authors:  Timothy A Sullivan; Eldon E Geisert; Justin P Templeton; Tonia S Rex
Journal:  Exp Eye Res       Date:  2012-01-27       Impact factor: 3.467

2.  Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies.

Authors:  Natalie D Bull; Thomas V Johnson; Guncha Welsapar; Nicholas W DeKorver; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

3.  Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy.

Authors:  Freya M Mowat; Francisco Gonzalez; Ulrich F O Luhmann; Clemens A Lange; Yanai Duran; Alexander J Smith; Patrick H Maxwell; Robin R Ali; James W B Bainbridge
Journal:  Am J Pathol       Date:  2012-02-17       Impact factor: 4.307

4.  A human cell atlas of fetal gene expression.

Authors:  Junyue Cao; Diana R O'Day; Hannah A Pliner; Paul D Kingsley; Mei Deng; Riza M Daza; Michael A Zager; Kimberly A Aldinger; Ronnie Blecher-Gonen; Fan Zhang; Malte Spielmann; James Palis; Dan Doherty; Frank J Steemers; Ian A Glass; Cole Trapnell; Jay Shendure
Journal:  Science       Date:  2020-11-13       Impact factor: 47.728

5.  Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA/2J glaucomatous mice.

Authors:  Timothy A Sullivan; Eldon E Geisert; Jessica Hines-Beard; Tonia S Rex
Journal:  Hum Gene Ther       Date:  2011-06-08       Impact factor: 5.695

6.  A Thy1-CFP DBA/2J mouse line with cyan fluorescent protein expression in retinal ganglion cells.

Authors:  Iona D Raymond; Angela L Pool; Alejandro Vila; Nicholas C Brecha
Journal:  Vis Neurosci       Date:  2009-11-23       Impact factor: 3.241

7.  Inhibiting Matrix Metalloproteinase 3 Ameliorates Neuronal Loss in the Ganglion Cell Layer of Rats in Retinal Ischemia/Reperfusion.

Authors:  Tu Hu; Qiuting You; Dan Chen; Jianbin Tong; Lei Shang; Jia Luo; Yi Qiu; Huimin Yu; Leping Zeng; Jufang Huang
Journal:  Neurochem Res       Date:  2016-01-30       Impact factor: 3.996

8.  Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury.

Authors:  Roberta Brambilla; Andres Hurtado; Trikaldarshi Persaud; Kim Esham; Damien D Pearse; Martin Oudega; John R Bethea
Journal:  J Neurochem       Date:  2009-05-26       Impact factor: 5.372

9.  Adeno-associated virus-mediated expression of growth-associated protein-43 aggravates retinal ganglion cell death in experimental chronic glaucomatous injury.

Authors:  Chukai Huang; Ling-Ping Cen; Lifang Liu; Simone G Leaver; Alan R Harvey; Qi Cui; Chi Pui Pang; Mingzhi Zhang
Journal:  Mol Vis       Date:  2013-06-27       Impact factor: 2.367

10.  Synaptophysin expression in rat retina following acute high intraocular pressure.

Authors:  Chen Dan; Tong Jian-Bin; Wang Hui; Zeng Le-Ping; Zhou Jin; Huang Ju-Fang; Luo Xue-Gang
Journal:  Acta Histochem Cytochem       Date:  2008-12-19       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.